Science Explorer Interactive view Map
Topic · Genetics

Hemoglobinopathies and Related Disorders

Hemoglobinopathies and Related Disorders is a research topic within Genetics. Science Explorer counts 54k research works in it since 1950. 12.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the genetic, clinical, and epidemiological aspects of hemoglobin disorders, including sickle-cell disease and thalassemia. It covers topics such as hemolysis, fetal hemoglobin regulation, iron overload, pulmonary hypertension, and the use of transfusion therapy. The genetic regulation of erythropoiesis by factors like GATA1 and BCL11A is also a focus of several papers.

  • Sickle-cell Disease
  • Thalassemia
  • Hemolysis
  • Fetal Hemoglobin
  • Iron Overload
  • Genetic Regulation
  • Pulmonary Hypertension
  • Transfusion Therapy
  • GATA Factor
  • Epidemiology
Research works
54k
fractional, since 1950
In the world top 10%
6.6k
per year above
Top-10% rate
12.2%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+29%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Hemoglobinopathies and Related Disorders research?

By volume, the United States and India publish the most (2.5k and 837 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 2.5k works
  2. 2 India 837 works
  3. 3 China 597 works
  4. 4 Brazil 571 works
  5. 5 United Kingdom 296 works
  6. 6 Italy 264 works
  7. 7 Pakistan 260 works
  8. 8 France 258 works
  9. 9 Nigeria 219 works
  10. 10 Saudi Arabia 195 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 41.6%India: 14.0%China: 10.0%Brazil: 9.5%6 others listed: 24.9%42%largest
United States2,496 · 41.6%India837 · 14.0%China597 · 10.0%Brazil571 · 9.5%6 others listed1,493 · 24.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Hemoglobinopathies and Related Disorders research?

By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Hemoglobinopathies and Related Disorders research, followed by University of Pittsburgh and Emory University.

By volume, 2022–2025

  1. 1 University of North Carolina at Chapel HillUnited States 40 works
  2. 2 University of PittsburghUnited States 37 works
  3. 3 Emory UniversityUnited States 36 works
  4. 4 Universidade Estadual de Campinas (UNICAMP)Brazil 35 works
  5. 5 St. Jude Children's Research HospitalUnited States 35 works
  6. 6 University of Alabama at BirminghamUnited States 35 works
  7. 7 University of Illinois ChicagoUnited States 34 works
  8. 8 Ain Shams UniversityEgypt 28 works
  9. 9 Children's Hospital of PhiladelphiaUnited States 26 works
  10. 10 Chiang Mai UniversityThailand 26 works

Who are the leading researchers in Hemoglobinopathies and Related Disorders?

The most-cited researchers publishing on Hemoglobinopathies and Related Disorders include Giuseppe Remuzzi and Winfried März.

  1. 1 Giuseppe Remuzzi Italy 8.1k citations
  2. 2 Winfried März Germany 5.2k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Hemoglobinopathies and Related Disorders research done?

The largest centres of Hemoglobinopathies and Related Disorders research in 2022–2025 are Paris (France), London (United Kingdom), São Paulo (Brazil) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Memphis.

Largest cities, 2022–2025

  1. 1 Paris France 139 works
  2. 2 London United Kingdom 129 works
  3. 3 São Paulo Brazil 128 works
  4. 4 New York United States 121 works
  5. 5 Boston United States 97 works
  6. 6 Atlanta United States 85 works
  7. 7 Philadelphia United States 81 works
  8. 8 New Delhi India 81 works
  9. 9 Riyadh Saudi Arabia 77 works
  10. 10 Chicago United States 74 works

Where it is the local speciality

  1. MemphisUS · 53.4 works13×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Hemoglobinopathies and Related Disorders than the world average.

See Hemoglobinopathies and Related Disorders on the map

Where is the best place to study Hemoglobinopathies and Related Disorders?

Among universities, judged by research, Kampala International University, Muhimbili University of Health and Allied Sciences and Chiang Mai University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 12.74%fractional works in this node (log) →share in the world top 10% →Kampala International University: 20, 38.5%Muhimbili University of Health and Allied Sciences: 11, 16.3%Chiang Mai University: 26, 13.0%Africa University: 13, 16.2%University of Alabama at Birmingham: 35, 8.4%Institute of Medical Sciences: 24, 2.5%University of Illinois Chicago: 34, 7.1%University of Basrah: 19, 2.0%Makerere University: 10, 13.3%University of Pittsburgh: 37, 10.1%Kampala Internationa…Muhimbili University…Africa UniversityChiang Mai University
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Kampala International UniversityUganda 79.738.5%31.8×20 —
2 Muhimbili University of Health and Allied SciencesTanzania 61.216.3%27.6×11 +148.4%
3 Chiang Mai UniversityThailand 60.913.0%9.7×26 +69.8%
4 Africa UniversityZimbabwe 55.916.2%91.3×13 —
5 University of Alabama at BirminghamUnited States 54.98.4%8.5×35 +63.7%
6 Institute of Medical SciencesIndia 54.92.5%8.9×24 +353.6%
7 University of Illinois ChicagoUnited States 53.17.1%7.8×34 +65.2%
8 University of BasrahIraq 52.82.0%9.4×19 +663.9%
9 Makerere UniversityUganda 52.413.3%6.4×10 +274.0%
10 University of PittsburghUnited States 52.110.1%5.7×37 +82.9%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Hemoglobinopathies and Related Disorders research growing?

Output in 2018–2022 was 29% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Hemoglobinopathies and Related Disorders.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.